CLOs on the Move


 
Cutera was established in the San Francisco Bay Area (Brisbane) in 1998 by veteran laser and optical engineers. As the pioneer of Nd:YAG technology, CUTERA® is the trusted authority in Face + Body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. At Cutera, we`re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. CUTERA`s premium portfolio of products include: xeo®, truSculpt® and excel V™. In 2014, CUTERA introduced two new exciting additions to their family of premium ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.cutera.com
  • 3240 Bayshore Boulevard
    Brisbane, CA USA 94005
  • Phone: 415.657.5500

Executives

Name Title Contact Details
Stephana Patton
Chief Legal Officer Profile
Darren Alch
General Counsel Profile

Similar Companies

Nova Health Systems Inc

Nova Health Systems Inc is a Utica, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Michelson Laboratories

Michelson Laboratories, Inc. is a Commerce, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

CCS Medical

Home Delivered Medical Supplies. A one-stop solution-from selecting and using your products, to shipments and insurance.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.

AART

AART is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.